Dupilumab Maintains Its Effectiveness Up to Five Years in Patients With Eczema
23.8 percent of patients discontinued dupilumab, with adverse events and ineffectiveness the most common reasons
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.